Rheumatology COVID-19 registry

nivesity of California Sanfrancisco0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue
Sponsor: nivesity of California Sanfrancisco
Status: Not yet recruiting
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Observational

Investigators

Sponsor

nivesity of California Sanfrancisco

Eligibility Criteria

Inclusion Criteria

•Patients with Rheumatological autoimmune disease who develop COVID\-19

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting

Not Applicable

ational Clinical Registry of COVID 19Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

CTRI/2020/08/027164Indian Council of Medical Research

Recruiting

Not Applicable

Registry of the patients with rheumatoid arthritis treated with Biologics in routine clinical practice.Rheumatoid Arthritis

JPRN-UMIN000007224FRAB Registry2,000

Recruiting

Not Applicable

Corrona Japan Rheumatoid Arthritis (RA) RegistryRheumatoid Arthritis

JPRN-UMIN000021394CorEvitas, LLC2,600

Recruiting

Not Applicable

A multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) studyRheumatoid arthritis

JPRN-UMIN000026558agoya University Hospital5,000

Recruiting

Not Applicable

COVID-19 RegistryCOVID-19

JPRN-UMIN000039873ational Center for Global Health and Medicine99,999